These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5899511)

  • 1. [Progressive scleroderma cured by the oral and parenteral administration of paramethyl-isopropyl-phenol (thymol)].
    Buccellato G
    G Ital Dermatol Minerva Dermatol; 1965; 106(4):373-6. PubMed ID: 5899511
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of the anti-HeLa phenomenon in the blood of subjects with skin neoplasms treated with paramethyl-isopropyl-phenol (thymol)].
    Buccellato G; Valguarnera G
    Boll Soc Ital Biol Sper; 1969 Mar; 45(6):343-5. PubMed ID: 5399627
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibiting power of paramethyl-isopropyl-phenol (thymol) on the development of ascites tumor in the rat. Preliminary note].
    Buccellato G
    Boll Soc Ital Biol Sper; 1965 Jul; 41(14):757. PubMed ID: 5875916
    [No Abstract]   [Full Text] [Related]  

  • 4. Paramethyl-isopropyl-phenol (thymol) and caffeine in the treatment of skin neoplasms.
    Buccellato G
    G Ital Chemioter; 1975; 22(1-2):71-74. PubMed ID: 1235357
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dermatomyositis cured by administration of para-methyl-isopropyl-phenol (thymol)].
    Buccellato G
    G Ital Dermatol Minerva Dermatol; 1965; 106(1):89-94. PubMed ID: 5899503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective action of paramethyl-isopropyl-phenol (thymol) on tissues in intense anaplastic-dysplastic proliferative activity].
    Buccellato G
    Boll Soc Ital Biol Sper; 1965 Sep; 41(17):986-8. PubMed ID: 5878481
    [No Abstract]   [Full Text] [Related]  

  • 7. [Paramethyl-isopropyl-phenol (thymol) in the therapy of some cutaneous diseases: (A) resolution of lupus erythematosus (by general administration); (B) cure of cutaneous cancer (by intra-lesional infiltration)].
    Buccellato G
    G Ital Dermatol Minerva Dermatol; 1966; 107(4):351-62. PubMed ID: 6014413
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytolytic power of paramethyl-isopropyl-phenol (thymol) in scaled dilutions of Hela cells].
    Buccellato G; Valguarnera G
    Boll Soc Ital Biol Sper; 1965 Jul; 41(14):761-2. PubMed ID: 5875917
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new method for biological assay, in the blood, of factors inhibiting the development of cells in culture. Investigations in subjects treated with paramethyl-isopropyl-phenol (thymol)].
    Buccellato G; Valguarnera G
    Boll Soc Ital Biol Sper; 1965 Jul; 41(14):758-61. PubMed ID: 5896210
    [No Abstract]   [Full Text] [Related]  

  • 10. Global improvement of systemic scleroderma under long-term administration of octreotide.
    Descamps V; Duval X; Crickx B; Bouscarat F; Coffin B; Belaich S
    Eur J Dermatol; 1999 Sep; 9(6):446-8. PubMed ID: 10491499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The action of paramethyl-isopropyl-phenol (thymol) on explants of chick embryo heart and liver in cultures in vitro].
    Buccellato G; Valguarnera G
    Boll Soc Ital Biol Sper; 1964 Jul; 40(13):740-2. PubMed ID: 5896351
    [No Abstract]   [Full Text] [Related]  

  • 12. [KAPOSI'S DISEASE CURED BY THE ADMINISTRATION OF PARAMETHYL-ISOPROPYLPHENOL (THYMOL)].
    BUCCELLATO G
    G Ital Dermatol; 1964; 105():419-30. PubMed ID: 14216242
    [No Abstract]   [Full Text] [Related]  

  • 13. [Do we treat systemic sclerosis (progressive scleroderma) for too short a period?].
    Steigleder GK
    Z Hautkr; 1984 Aug; 59(16):1051-2. PubMed ID: 6435323
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse effect of corticosteroid therapy in a patient with progressive systemic sclerosis (generalized scleroderma).
    Kornell S
    Manit Med Rev; 1966 Nov; 46(9):579-82. PubMed ID: 5979403
    [No Abstract]   [Full Text] [Related]  

  • 15. [Madecassol treatment of systemic and localized scleroderma].
    Guseva NG; Starovoĭtova MN; Mach ES
    Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of interferon-gamma containing gel for local treatment of skin ulcers in autoimmune vasculitides and skin changes in progressive systemic sclerosis.
    Arnaudova P; Rashkov R; Tsanev R
    J Rheumatol; 1993 Aug; 20(8):1445-6. PubMed ID: 8230042
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural remedies for scleroderma.
    Gaby AR
    Altern Med Rev; 2006 Sep; 11(3):188-95. PubMed ID: 17217320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [1. Progressive scleroderma. 2. Pustular palmo-plantar psoriasis].
    Grimmer H
    Z Haut Geschlechtskr; 1966 Jun; 40(9):Suppl:lix-lxii. PubMed ID: 5996383
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation factor XIII in scleroderma.
    Jullien D; Souillet AL; Faure M; Claudy A
    Eur J Dermatol; 1998 Jun; 8(4):231-4. PubMed ID: 9649677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.